Article
Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.
Neurogenetics - 1 Feb 2009
Kauwe John S K, Wang Jun, Mayo Kevin, Morris John C, Fagan Anne M, Holtzman David M, Goate Alison M
Abstract excerpt
The use of quantitative endophenotypes in genetic studies may provide greater power, allowing for the use of powerful statistical methods and a biological model for the effects of the disease-associated genetic variation. Cerebrospinal fluid (CSF) amyloid beta (Abeta) levels are promising endophenotypes for late-onset Alzheimer's disease (LOAD) and show correlation with LOAD status and Abeta deposition. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
